• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Pilot Randomized Controlled Trial.

作者信息

Hu Jinbo, Zhou Qixin, Sun Yue, Feng Zhengping, Yang Jun, He Wenwen, Song Ying, Wang Yue, Chen Xiangjun, Shen Hang, Jing Ying, Yang Shumin, Li Qifu

机构信息

Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, China (J.H., Q.Z., Y.S., Z.F., W.H., Y.S., Y.W., X.C., H.S., Y.J., S.Y., Q.L.).

Department of Medicine, Monash University, Clayton, VIC, Australia (J.Y.).

出版信息

Circulation. 2025 Jan 14;151(2):196-198. doi: 10.1161/CIRCULATIONAHA.124.071452. Epub 2025 Jan 13.

DOI:10.1161/CIRCULATIONAHA.124.071452
PMID:39804908
Abstract
摘要

相似文献

1
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Pilot Randomized Controlled Trial.非奈利酮治疗原发性醛固酮增多症患者的疗效和安全性：一项前瞻性随机对照试验。
Circulation. 2025 Jan 14;151(2):196-198. doi: 10.1161/CIRCULATIONAHA.124.071452. Epub 2025 Jan 13.
2
A Trial of Finerenone in a Patient with Primary Aldosteronism.原发性醛固酮增多症患者的非奈利酮临床试验。
Kidney Blood Press Res. 2024;49(1):839-842. doi: 10.1159/000541441. Epub 2024 Sep 18.
3
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.非奈利酮用于射血分数轻度降低或保留的心力衰竭女性和男性：FINEARTS-HF随机临床试验的二次分析
JAMA Cardiol. 2025 Jan 1;10(1):59-70. doi: 10.1001/jamacardio.2024.4613.
4
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial.近期心力衰竭事件恶化患者使用非奈利酮：FINEARTS-HF试验
J Am Coll Cardiol. 2025 Jan 21;85(2):106-116. doi: 10.1016/j.jacc.2024.09.004. Epub 2024 Sep 29.
5
Efficacy and safety of finerenone in patients with chronic kidney disease: a systematic review with meta-analysis and trial sequential analysis.非奈利酮治疗慢性肾脏病患者的疗效和安全性：系统评价与荟萃分析及试验序贯分析。
Ann Palliat Med. 2021 Jul;10(7):7428-7439. doi: 10.21037/apm-21-763.
6
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial.非奈利酮在轻度射血分数降低或保留的心力衰竭射血分数范围内的疗效和安全性：FINEARTS-HF试验的预设分析
Circulation. 2025 Jan 7;151(1):45-58. doi: 10.1161/CIRCULATIONAHA.124.072011. Epub 2024 Sep 29.
7
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF.非奈利酮治疗射血分数保留的心力衰竭（HFmrEF/HFpEF）时肾小球滤过率的初始下降：FINEARTS-HF的预设分析
J Am Coll Cardiol. 2025 Jan 21;85(2):173-185. doi: 10.1016/j.jacc.2024.11.020.
8
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.非奈利酮治疗糖尿病肾病患者蛋白尿的疗效：一项随机临床试验。
JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081.
9
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.非糖尿病慢性肾脏病患者使用非奈利酮（除标准治疗外）延缓肾病进展的随机试验（FIND-CKD）的设计与基线特征
Nephrol Dial Transplant. 2025 Feb 4;40(2):308-319. doi: 10.1093/ndt/gfae132.
10
Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.非奈利酮与心力衰竭患者的心房颤动：FINEARTS-HF随机临床试验的二次分析
JAMA Cardiol. 2025 Mar 29. doi: 10.1001/jamacardio.2025.0848.

引用本文的文献

1
Aldosterone and Cardiovascular Risk Across the Lifespan.醛固酮与一生的心血管风险
Metabolites. 2025 Aug 17;15(8):553. doi: 10.3390/metabo15080553.
2
Multimodality Imaging in Aldosterone-Induced Cardiomyopathy: Early Detection and Prognostic Implications.醛固酮诱导性心肌病的多模态成像：早期检测及预后意义
Diagnostics (Basel). 2025 Jul 29;15(15):1896. doi: 10.3390/diagnostics15151896.